Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy

BACKGROUND: Patients with metastatic urothelial carcinoma (mUC) have an uncertain prognosis. The aim of the current study was to evaluate the prognostic potential of a skeletal muscle mass reduction index measured by computed tomography (CT) for mUC patients undergoing second-line gemcitabine and do...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Asian Pac J Cancer Prev
Main Authors: Nagai, Takashi, Naiki, Taku, Iida, Keitaro, Nozaki, Satoshi, Etani, Toshiki, Sugiyama, Yosuke, Ando, Ryosuke, Yanase, Takahiro, Chaya, Ryosuke, Moritoki, Yoshinobu, Kobayashi, Daichi, Akita, Hidetoshi, Okamura, Takehiko, Yasui, Takahiro
Formato: Artigo
Idioma:Inglês
Publicado: West Asia Organization for Cancer Prevention 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6982681/
https://ncbi.nlm.nih.gov/pubmed/31653146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.10.2995
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares